These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


263 related items for PubMed ID: 6337173

  • 1. Effect of graded intraduodenal glucose infusions on the release and physiological action of gastric inhibitory polypeptide.
    McCullough AJ, Miller LJ, Service FJ, Go VL.
    J Clin Endocrinol Metab; 1983 Feb; 56(2):234-41. PubMed ID: 6337173
    [Abstract] [Full Text] [Related]

  • 2. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
    Andersen DK, Elahi D, Brown JC, Tobin JD, Andres R.
    J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
    [Abstract] [Full Text] [Related]

  • 3. Gastric inhibitory polypeptide and insulin: response to intraduodenal and intravenous glucose infusions in fetal and neonatal pigs.
    Kühl C, Hornnes PJ, Jensen SL, Lauritsen KB.
    Endocrinology; 1980 Nov; 107(5):1446-50. PubMed ID: 7000494
    [Abstract] [Full Text] [Related]

  • 4. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W.
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Radioimmunoassay of gastric inhibitory polypeptide (GIP) and the effect of intraduodenal acidification on glucose-stimulated and unstimulated GIP release in humans.
    Flaten O.
    Scand J Gastroenterol; 1981 Apr; 16(4):545-54. PubMed ID: 7034154
    [Abstract] [Full Text] [Related]

  • 7. Effect of intraduodenal and intravenous triglyceride infusions on plasma gastric inhibitory polypeptide and insulin in fetal and neonatal pigs.
    Kühl C, Hornnes PJ, Jensen SL, Lauritsen KB.
    Diabetologia; 1982 Jul; 23(1):41-4. PubMed ID: 6749583
    [Abstract] [Full Text] [Related]

  • 8. Response of circulating somatostatin, insulin, gastrin and GIP, to intraduodenal infusion of nutrients in normal man.
    Lucey MR, Fairclough PD, Wass JA, Kwasowski P, Medbak S, Webb J, Rees LH.
    Clin Endocrinol (Oxf); 1984 Sep; 21(3):209-17. PubMed ID: 6148162
    [Abstract] [Full Text] [Related]

  • 9. Glucose-dependent insulinotropic polypeptide augmentation of insulin. Physiology or pharmacology?
    Sarson DL, Wood SM, Kansal PC, Bloom SR.
    Diabetes; 1984 Apr; 33(4):389-93. PubMed ID: 6368294
    [Abstract] [Full Text] [Related]

  • 10. Discrepant performance on oral and intravenous glucose tolerance tests: the role of gastric inhibitory polypeptide.
    Elahi D, Andersen DK, Tobin JD, Andres R.
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1199-203. PubMed ID: 7014599
    [Abstract] [Full Text] [Related]

  • 11. The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man.
    Falko JM, Crockett SE, Cataland S, O'Dorisio TM, Kramer W, Mazzaferri EL.
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):587-93. PubMed ID: 7014042
    [Abstract] [Full Text] [Related]

  • 12. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus.
    Elahi D, Andersen DK, Muller DC, Tobin JD, Brown JC, Andres R.
    Diabetes; 1984 Oct; 33(10):950-7. PubMed ID: 6383904
    [Abstract] [Full Text] [Related]

  • 13. Dose-dependent increase in concentrations of gastric inhibitory polypeptide and pancreatic polypeptide after small amounts of glucose intraduodenally in man.
    Flaten O, Tronier B.
    Scand J Gastroenterol; 1982 Aug; 17(5):677-80. PubMed ID: 7178831
    [Abstract] [Full Text] [Related]

  • 14. Preceding hyperinsulinemia prevents demonstration of insulin effect on fat-induced gastric inhibitory polypeptide (GIP).
    Stöckmann F, Ebert R, Creutzfeldt W.
    Diabetes; 1984 Jun; 33(6):580-5. PubMed ID: 6373462
    [Abstract] [Full Text] [Related]

  • 15. Influence of gastric inhibitory polypeptide antiserum on glucose-induced insulin secretion in rats.
    Ebert R, Creutzfeldt W.
    Endocrinology; 1982 Nov; 111(5):1601-6. PubMed ID: 6751797
    [Abstract] [Full Text] [Related]

  • 16. The insulinotropic effect of endogenous gastric inhibitory polypeptide in normal subjects.
    Crockett SE, Cataland S, Falko JM, Mazzaferri EL.
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1098-103. PubMed ID: 932174
    [Abstract] [Full Text] [Related]

  • 17. The effect of age and glycemic level on the response of the beta-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin.
    Meneilly GS, Ryan AS, Minaker KL, Elahi D.
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2925-32. PubMed ID: 9709971
    [Abstract] [Full Text] [Related]

  • 18. Comparative effects of intraduodenal fat and glucose on the gut-incretin axis in healthy males.
    Wu T, Rayner CK, Watson LE, Jones KL, Horowitz M, Little TJ.
    Peptides; 2017 Sep; 95():124-127. PubMed ID: 28800948
    [Abstract] [Full Text] [Related]

  • 19. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8.
    Nauck M, Schmidt WE, Ebert R, Strietzel J, Cantor P, Hoffmann G, Creutzfeldt W.
    J Clin Endocrinol Metab; 1989 Sep; 69(3):654-62. PubMed ID: 2668324
    [Abstract] [Full Text] [Related]

  • 20. Lowering of fasting and food stimulated serum immunoreactive gastric inhibitory polypeptide (GIP) by glucagon.
    Ebert R, Arnold R, Creutzfeldt W.
    Gut; 1977 Feb; 18(2):121-7. PubMed ID: 856672
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.